Genmab — April 2014
-
der var et voldsomt sell-off i den sidste halve time, hvor US biotek oven i købet performede ret godt. Men op til luk var der en marginal stigning og lukkeauktionen selv var relativt afdæmpet med lidt over 20k aktier. Umiddelbart vil mit gæt være, at ingen ved noget endnu
-
Er det mon tid til at samle op?
-
-
det helt store problem - som jeg ser der - er, at bliver arzerra ikke godtkendt nu, så vil der også opstå tvivl om dara - og så bliver der for alvor ballade
-
sker der noget specielt på gmxay?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind